Companies
Intertek
Global Compliance — In vitro toxicology.
- Country
- United Kingdom
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| market-access-commercial | ✓ | ✓ | — | ✓ |
| regulatory-legal | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsaemaechadefra
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Production site | Manchester, UK and Melbourn, Cambridge, UK (Pharmaceutical Services) | intertek.com |
| Certification | GLP, GCP, and GMP compliant laboratory (Manchester) | cms.mhra.gov.uk · intertek.com |
| Regulatory approval | Inspected and approved by MHRA (UK) for GLP and GMP compliance (Human and Vet Medicines); Human Tissue Authority license holder | cms.mhra.gov.uk · intertek.com |
| Headcount | 45,425 employees globally (as of 2025-12-31) | w3inte.intertek.com |
| Revenue | £3,431.6 million (for the year ended 2025-12-31) | w3inte.intertek.com |
Independent sources: cms.mhra.gov.uk
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Distributor compliance auditing (GDP) | regulatory-legal | Low | → |
| Health-claim substantiation (EFSA 13/14) | market-access-commercial | High | → |
| Multi-jurisdictional bio-product registration | regulatory-legal | Low | → |
| Novel food approval-as-a-service (EU/UK/SG) | regulatory-legal | Medium | → |
| REACH compliance for bio-chemicals | market-access-commercial | Low | → |
| Sensory evaluation panels | market-access-commercial | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.